Cargando…

The conjunctival microbiome before and after azithromycin mass drug administration for trachoma control in a cohort of Tanzanian children

BACKGROUND: Trachoma, caused by ocular infection with Chlamydia trachomatis, is a neglected tropical disease that can lead to blinding pathology. Current trachoma control programmes have successfully used mass drug administration (MDA) with azithromycin to clear C. trachomatis infection and reduce t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pickering, Harry, Ramadhani, Athumani M., Massae, Patrick, Mafuru, Elias, Malisa, Aiweda, Mbuya, Kelvin, Makupa, William, Mtuy, Tara, Derrick, Tamsyn, Houghton, Joanna, Bailey, Robin L., Mabey, David C. W., Burton, Matthew J., Holland, Martin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9619060/ https://www.ncbi.nlm.nih.gov/pubmed/36324475 http://dx.doi.org/10.3389/fpubh.2022.1015714

Ejemplares similares

Immunopathogenesis of Progressive Scarring Trachoma: Results of a 4-Year Longitudinal Study in Tanzanian Children
por: Derrick, Tamsyn, et al.
Publicado: (2020)

Progression of scarring trachoma in Tanzanian children: A four-year cohort study
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community
por: Ramadhani, Athumani M., et al.
Publicado: (2019)

DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas
por: Derrick, Tamsyn R., et al.
Publicado: (2020)

Immunofibrogenic Gene Expression Patterns in Tanzanian Children with Ocular Chlamydia trachomatis Infection, Active Trachoma and Scarring: Baseline Results of a 4-Year Longitudinal Study
por: Ramadhani, Athumani M., et al.
Publicado: (2017)

Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data
por: Goncalves, Adriana, et al.
Publicado: (2016)

Longitudinal changes in tear cytokines and antimicrobial proteins in trachomatous disease
por: Barton, Amber, et al.
Publicado: (2023)

miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease
por: Derrick, Tamsyn, et al.
Publicado: (2017)

Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes
por: Butcher, Robert, et al.
Publicado: (2017)

Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells
por: Hu, Victor H., et al.
Publicado: (2016)

The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment
por: Ramadhani, Athumani M., et al.
Publicado: (2016)

Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma
por: Pickering, Harry, et al.
Publicado: (2019)

Non-Chlamydial Bacterial Infection and Progression of Conjunctival Scarring in Trachoma
por: Hu, Victor H., et al.
Publicado: (2018)

In Vivo Confocal Microscopy in Scarring Trachoma
por: Hu, Victor H., et al.
Publicado: (2011)

Pathogenesis of Progressive Scarring Trachoma in Ethiopia and Tanzania and Its Implications for Disease Control: Two Cohort Studies
por: Burton, Matthew J., et al.
Publicado: (2015)

Conjunctival transcriptome profiling of Solomon Islanders with active trachoma in the absence of Chlamydia trachomatis infection
por: Vasileva, Hristina, et al.
Publicado: (2018)

Serology for Trachoma Surveillance after Cessation of Mass Drug Administration
por: Martin, Diana L., et al.
Publicado: (2015)

Conjunctival MicroRNA Expression in Inflammatory Trachomatous Scarring
por: Derrick, Tamsyn, et al.
Publicado: (2013)

Post-Operative Recurrent Trachomatous Trichiasis Is Associated with Increased Conjunctival Expression of S100A7 (Psoriasin)
por: Burton, Matthew J., et al.
Publicado: (2012)

Non-Participation during Azithromycin Mass Treatment for Trachoma in The Gambia: Heterogeneity and Risk Factors
por: Edwards, Tansy, et al.
Publicado: (2014)

Correction: Post-Operative Recurrent Trachomatous Trichiasis Is Associated with Increased Conjunctival Expression of S100A7 (Psoriasin)
por: Burton, Matthew J., et al.
Publicado: (2013)

Mass Treatment with Azithromycin for Trachoma Control: Participation Clusters in Households
por: Ssemanda, Elizabeth N., et al.
Publicado: (2010)

Trachoma and Ocular Chlamydial Infection in the Era of Genomics
por: Derrick, Tamsyn, et al.
Publicado: (2015)

Mass drug administration with azithromycin for trachoma elimination and the population structure of Streptococcus pneumoniae in the nasopharynx
por: Gladstone, Rebecca A., et al.
Publicado: (2021)

Impact of Community Mass Treatment with Azithromycin for Trachoma Elimination on the Prevalence of Yaws
por: Marks, Michael, et al.
Publicado: (2015)

The conjunctival transcriptome in Ethiopians after trichiasis surgery: associations with the development of eyelid contour abnormalities and the effect of oral doxycycline treatment
por: Derrick, Tamsyn, et al.
Publicado: (2022)

A Randomized Trial of Two Coverage Targets for Mass Treatment with Azithromycin for Trachoma
por: West, Sheila K., et al.
Publicado: (2013)

Eyescores: an open platform for secure electronic data and photographic evidence collection in ophthalmological field studies
por: Roberts, Chrissy h, et al.
Publicado: (2013)

In Vivo Confocal Microscopy of Trachoma in Relation to Normal Tarsal Conjunctiva
por: Hu, Victor H., et al.
Publicado: (2011)

Association between Ocular Bacterial Carriage and Follicular Trachoma Following Mass Azithromycin Distribution in The Gambia
por: Burr, Sarah E., et al.
Publicado: (2013)

Impact of mass drug administration of azithromycin for trachoma elimination on prevalence and azithromycin resistance of genital Mycoplasma genitalium infection
por: Harrison, Mark Andrew, et al.
Publicado: (2019)

Conjunctival FOXP3 Expression in Trachoma: Do Regulatory T Cells Have a Role in Human Ocular Chlamydia trachomatis Infection?
por: Faal, Nkoyo, et al.
Publicado: (2006)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Anthropometric indices of Gambian children after one or three annual rounds of mass drug administration with azithromycin for trachoma control
por: Burr, Sarah E, et al.
Publicado: (2014)

Conjunctival FOXP (3) in Trachoma: T Cells Not Specified
por: Probst-Kepper, Michael
Publicado: (2006)

Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma
por: Butcher, Robert, et al.
Publicado: (2020)

The Global Burden of Trachoma: A Review
por: Burton, Matthew J., et al.
Publicado: (2009)

Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection
por: Derrick, Tamsyn, et al.
Publicado: (2016)

Mass Treatment with Azithromycin for Trachoma: When Is One Round Enough? Results from the PRET Trial in The Gambia
por: Harding-Esch, Emma M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_vfvi6n8t1084j180ldrjdlg17l